Allogeneic stem cell transplantation for patients with acute myeloid leukemia or myelodysplastic syndrome who have chromosome 5 and/or 7 abnormalities

被引:1
|
作者
van der Straaten, Hanneke M. [1 ]
van Biezen, Anja [2 ,3 ]
Brand, Ronald [2 ,3 ]
Schattenberg, Anton V. M. B. [4 ]
Egeler, Roel M. [5 ]
Barge, Renee M. [6 ]
Cornelissen, Jan J. [7 ]
Schouten, Harry C. [8 ]
Ossenkoppele, Gert J. [9 ]
Verdonck, Leo F. [1 ]
机构
[1] Univ Med Ctr Utrecht, Dept Hematol, G03-647,Heidelberglaan 100, NL-3584 CX Utrecht, Netherlands
[2] Netherlands Stem Cell Transplant Registry TYPHON, Leiden, Netherlands
[3] Dept Med Stat, Leiden, Netherlands
[4] Univ Med Ctr Nijmegen, Dept Hematol, Nijmegen, Netherlands
[5] Leiden Univ, Dept Pediat, Med Ctr, Leiden, Netherlands
[6] Leiden Univ, Dept Hematol, Med Ctr, Leiden, Netherlands
[7] Erasmus MC, Daniel den Hoed Canc Ctr, Dept Hematol, Rotterdam, Netherlands
[8] Univ Hosp Maastricht, Dept Hematol & Oncol, Maastricht, Netherlands
[9] Vrije Univ Amsterdam Med Ctr, Dept Hematol, Amsterdam, Netherlands
关键词
acute myeloid leukemia; myelodysplastic syndrome; allogeneic transplantation; del(5q)/-5; del(7q)/-7;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Backgrounds and Objectives. Chromosome 5 and/or 7 abnormalities are cytogenetic findings indicative of a poor prognosis in patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS). The only potential cure for such patients is allogeneic stem cell transplantation (SCT). As data on allogeneic SCT in this context are limited we did a retrospective study of allogeneic SCT in patients with AML or MDS who had chromosome 5 and/or 7 abnormalities. Design and Methods. This was a retrospective study of 65 patients (16 children, 49 adults) with AML (n=33) or MDS (n=32) who had chromosome 5 and/or 7 abnormalities and who underwent allogeneic SCT in six Dutch Centers between 1983 and 2001. Data on all these patients are recorded in the Netherlands Stem Cell Transplant Registry (Typhon). Results. The 3-year overall survival rate among all patients was 25%. Patients below the age of 40 years had significantly fewer relapses (40%) and better survival (38%) than those above the age of 40 (86% and 8%, respectively). Relapses were less frequent in recipients of unrelated grafts than in those whose grafts were from HLA-identical siblings (30% versus 69%). The development of acute graft-versus-host disease (GVHD) grades II-IV was independently associated with significantly higher transplant-related mortality (TRM). Patients with either chromosome 5 or chromosome 7 abnormalities had a significantly better survival than patients with both chromosome 5 and 7 abnormalities. These patients with poor-risk chromosome 5 and/or 7 abnormalities were compared with a group of patients with a secondary AML/MDS and normal cytogenetics and were found to have significantly more relapses and significantly worse survival but a similar TRM. Interpretation and Conclusions. We conclude that patients with AML or MDS with chromosome 5 and/or 7 abnormalities do rather poorly after allogeneic SCT, mainly because of the very high relapse rate. Nevertheless, this is the only approach that can cure some of these patients.
引用
收藏
页码:1339 / 1345
页数:7
相关论文
共 50 条
  • [1] Allogeneic stem cell transplantation for patients with acute myeloid leukemia or myelodysplastic syndrome having chromosome 5 and/or 7 abnormalities.
    van der Straaten, HM
    van Biezen, A
    Brand, R
    Schattenberg, AVMB
    Egeler, RM
    Barge, RMY
    Cornelissen, JJ
    Schouten, HC
    Ossenkoppele, GJ
    Verdonck, LF
    [J]. BLOOD, 2003, 102 (11) : 603A - 603A
  • [2] Allogeneic stem cell transplantation for patients with acute myeloid leukaemia or myelodysplastic syndrome having chromosome 5 and/or 7 abnormalities
    van der Straaten, HM
    van Biezen, A
    Brand, R
    Schattenberg, AVMB
    Egeler, RM
    Barge, RM
    Cornelissen, JJ
    Schouten, HC
    Ossenkoppele, GJ
    Verdonck, LF
    [J]. BONE MARROW TRANSPLANTATION, 2004, 33 : S32 - S32
  • [3] Allogeneic stem cell transplantation for secondary or therapy-related acute myeloid leukemia or myelodysplastic syndrome with chromosome 5 and/or 7 aberrations
    Hemmati, P.
    Terwey, T.
    Le Coutre, P.
    Massenkeil, G.
    Vuong, L.
    Doerken, B.
    Arnold, R.
    [J]. ONKOLOGIE, 2010, 33 : 168 - 168
  • [4] Stem cell therapy - indications to allogeneic transplantation in myelodysplastic syndrome and acute myeloid leukemia
    Beelen, D. W.
    [J]. ONKOLOGIE, 2012, 35 : 110 - 111
  • [5] PROGNOSTIC IMPACT OF COMPLEX KARYOTYPE ON OUTCOME OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN ACUTE MYELOID LEUKEMIA WITH CHROMOSOME 5 AND/OR 7 ABNORMALITIES
    Gindina, T. L.
    Mamayev, N.
    Bondarenko, S.
    Alyanskiy, A.
    Slesarchuk, O.
    Borovkova, A.
    Razumova, S.
    Nikolaeva, E.
    Gudozhnikova, Y.
    Zubarovskaya, L.
    Afanasyev, B.
    [J]. HAEMATOLOGICA, 2016, 101 : 669 - 670
  • [6] Sequential Allogeneic Stem Cell Transplantation in High Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome
    Zavrelova, Alzbeta
    Radocha, Jakub
    Lanska, Miriam
    Zak, Pavel
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (02) : S312 - S312
  • [7] Extramedullary relapses after allogeneic stem cell transplantation for acute myeloid leukemia and myelodysplastic syndrome
    Clark, William B.
    Strickland, Stephen A.
    Barrett, A. John
    Savani, Bipin N.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (06): : 860 - 863
  • [8] ALLOGENEIC STEM CELL TRANSPLANTATION IN SECONDARY ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROME: OHSU EXPERIENCE
    Avraham, Perets G.
    Meyers, G.
    Kovacsovics, T.
    Curtin, P. T.
    Leis, J. F.
    Bains, T.
    Lemieux, A.
    Maziarz, R. T.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (02) : S347 - S347
  • [9] Splenomegaly Negatively Affects Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome after Allogeneic Stem Cell Transplantation
    Shimomura, Yoshimitsu
    Ono, Yuichiro
    Yoshioka, Satoshi
    Hiramoto, Nobuhiro
    Yonetani, Noboru
    Matsushita, Akiko
    Hashimoto, Hisako
    Ishikawa, Takayuki
    [J]. BLOOD, 2016, 128 (22)
  • [10] Lack of nucleophosmin mutation in patients with myelodysplastic syndrome and acute myeloid leukemia with chromosome 5 abnormalities
    Shiseki, Masayuki
    Kitagawa, Yukiko
    Wang, Yan-Hua
    Yoshinaga, Kentaro
    Kondo, Toshiaki
    Kuroiwa, Hanae
    Okada, Michiko
    Mori, Naoki
    Motoji, Toshiko
    [J]. LEUKEMIA & LYMPHOMA, 2007, 48 (11) : 2141 - 2144